No Grow, why have the BPs ignored NWBO?
Per your comments,
"Really?? BP's have completely ignored NWBO. They've had years to buy it for pocket change. No BP does deals with OTCs -- none have in the last decade. Merck. who's part of the SPORE trial, sees all the data and has made at least three other oncology deals and passed on NWBO. Nobody is going to do a deal with NWBO because they know the FDA has told NWBO they won't accept the DCVax-L P3 trial."
1) The BPs have ignored NWBO since NWBOs products would jeopardize the BPs profits from their current SOC. IMPO.
2) Yes, the BPs had years to buy NWBO, but they know the true value of NWBO and could not afford NWBO's stock price, IMPO.
3) Per your comments "No BP does deals with OTCs -- none have in the last decade", this topic has been addressed multiple times, the BPs know NWBO's capabilities and NWBOs disruptive factors to their bottom line, IMPO.
4) Per your comments, "Merck. who's part of the SPORE trial, sees all the data and has made at least three other oncology deals and passed on NWBO." Merck knows the value of NWBO and how DCVax could add value to Merck's products, you know this but fail to address the true facts, IMPO.
5) Per your comments, "Nobody is going to do a deal with NWBO because they know the FDA has told NWBO they won't accept the DCVax-L P3 trial." Wow, you know that the FDA is fully aware of the fact that DCVax works and it's only a matter of time before FDA should approve DCVax, IMPO.
In all, you know that DCVax works, and it should have been approved already, IMPO
Bullish
Market Data 
Markets 
